Stye and Chalazion Treatment in Las Vegas: Celluma LLLT and NuLids at Trendsetter Eyewear

If you have had a stye or chalazion once, you know how uncomfortable it can be. If you have had them repeatedly, you know how frustrating it is to be told to use warm compresses and wait — only to have another one appear a few weeks later.

Recurring styes and chalazia are not bad luck. They are almost always a sign of an underlying eyelid condition — most commonly meibomian gland dysfunction (MGD) or blepharitis — that is not being addressed. At Trendsetter Eyewear in Summerlin, Las Vegas, Dr. Cynthia Payne treats both the acute lesion and the root cause using two in-office therapies: Celluma Low Level Light Therapy (LLLT) and NuLids automated eyelid hygiene.

These two conditions are often confused — and they do look similar — but they are clinically distinct.

A stye (hordeolum) is an acute bacterial infection of an eyelid gland. It typically presents as a painful, red, tender lump at or near the eyelid margin. An external hordeolum involves the glands of Zeis or Moll at the lash base; an internal hordeolum involves a meibomian gland deeper in the eyelid. Styes often have a visible pus point and may drain on their own. They are caused by Staphylococcus aureus in the majority of cases.

A chalazion is a chronic, non-infectious blockage of a meibomian gland. It forms a firm, painless nodule — usually deeper in the eyelid than a stye — that does not resolve on its own without treatment. Chalazia develop when a meibomian gland orifice becomes obstructed and the retained lipid secretion triggers a granulomatous inflammatory response in the surrounding tissue.

The two conditions frequently overlap: an internal hordeolum that does not fully resolve can evolve into a chalazion. And both are significantly more common in patients with underlying MGD or blepharitis.

This is the question most patients are not getting a satisfying answer to. If you have had three styes in the past year, the bacteria are not the primary problem — the environment that allows them to thrive is.

The meibomian glands are oil-secreting glands embedded in the upper and lower eyelids. There are roughly 25–40 of them in each lid. Their job is to secrete a lipid layer onto the tear film that prevents evaporation. When these glands become obstructed — due to thickened secretions, inflammation, or bacterial biofilm at the lid margin — the stagnant oil becomes a breeding ground for bacteria and a trigger for granulomatous inflammation.

Meibomian gland dysfunction is the most common cause of recurrent styes and chalazia. MGD is also the leading cause of evaporative dry eye disease — so patients with recurrent eyelid lesions frequently have dry eye symptoms as well, even if they have never connected the two.

Blepharitis — chronic inflammation of the eyelid margins — compounds the problem. Anterior blepharitis involves the lash base and is often associated with Staphylococcus overgrowth or Demodex mite infestation. Posterior blepharitis involves the meibomian gland orifices and is essentially synonymous with MGD. Both forms disrupt the normal eyelid microenvironment and predispose patients to recurrent styes and chalazia.

Warm compresses alone do not adequately address either condition. They provide temporary relief by softening meibomian secretions, but they do not reduce the underlying inflammation, clear the biofilm, or restore gland function. That is why patients who rely on compresses alone continue to cycle through recurrences.

Dr. Payne's approach combines two complementary in-office therapies that address the problem from different angles.

Celluma is an FDA-cleared, non-thermal light therapy device that delivers specific wavelengths of red (630–660 nm) and near-infrared (810–850 nm) light to the periocular tissue. Unlike IPL, which uses intense pulsed light to target blood vessels and pigment, Celluma LLLT works through photobiomodulation — a process by which light energy is absorbed by cellular chromophores and converted into biochemical signals that reduce inflammation, stimulate cellular repair, and improve gland function.

For stye and chalazion patients, the clinical effects of Celluma LLLT include:

• Reduction of periocular inflammation — LLLT downregulates pro-inflammatory cytokines (IL-1β, TNF-α) and upregulates anti-inflammatory mediators, reducing the inflammatory burden in the eyelid tissue that drives both acute infections and chronic granulomatous lesions.
• Stimulation of meibomian gland secretion — Photobiomodulation improves mitochondrial function in meibomian gland acinar cells, enhancing their ability to produce and secrete healthy lipid.
• Acceleration of tissue healing — LLLT promotes fibroblast proliferation and collagen synthesis, which accelerates resolution of the granulomatous tissue in chalazia.
• Antimicrobial effect — Certain wavelengths of red light have demonstrated direct antimicrobial activity against Staphylococcus aureus and other eyelid pathogens.

Celluma treatment is comfortable and non-invasive. The device is positioned close to the closed eyelids and delivers light for a set treatment period. There is no heat, no discomfort, and no downtime. Most patients find it relaxing.

NuLids is an automated eyelid hygiene system that uses a gentle, oscillating micro-tip to exfoliate the eyelid margin, remove bacterial biofilm and debris from the lash base, and mechanically unblock meibomian gland orifices.

Manual lid scrubs — whether with commercial wipes or diluted baby shampoo — are significantly less effective than automated eyelid hygiene. The oscillating action of NuLids delivers a level of mechanical debridement that cannot be replicated manually, and the treatment is performed in-office under controlled conditions.

For stye and chalazion patients, NuLids addresses the biofilm and gland obstruction that warm compresses and manual hygiene leave behind. It is particularly effective for patients with anterior blepharitis, Demodex-associated lid disease, and posterior blepharitis with inspissated meibomian secretions.

The procedure is brief and well-tolerated. Patients typically describe a mild tingling sensation at the lid margin. There is no anesthesia required and no recovery period.

The combination of Celluma LLLT and NuLids addresses the underlying meibomian gland dysfunction and blepharitis that cause recurrent styes and chalazia — not just the visible lesion. This is the key difference between the approach at Trendsetter Eyewear and the standard warm-compress-and-wait protocol.

For patients with an active, acute stye, Dr. Payne will also evaluate whether antibiotic therapy is appropriate. For patients with a persistent chalazion that has not responded to conservative treatment, she will discuss the full range of options including intralesional steroid injection and referral for incision and curettage when indicated.

Your first visit will begin with a thorough evaluation of your eyelid health, including assessment of meibomian gland function, lid margin anatomy, and tear film quality. Dr. Payne uses slit-lamp biomicroscopy to examine the gland orifices and evaluate the degree of MGD and blepharitis present.

Based on this evaluation, she will recommend a treatment plan tailored to your specific condition. Most patients with recurrent styes or chalazia benefit from a series of Celluma LLLT sessions combined with in-office NuLids treatment, followed by a maintenance protocol to prevent recurrence.

You will also receive guidance on at-home eyelid hygiene practices that complement the in-office treatment — including appropriate lid wipe products, omega-3 supplementation for meibomian gland health, and environmental modifications relevant to the Las Vegas desert climate.

The desert climate of Las Vegas creates conditions that are unusually hard on the eyelid glands. Low ambient humidity — often below 20% indoors with air conditioning running — accelerates tear evaporation and places additional demand on the meibomian glands. Dry air also concentrates airborne particulates and allergens that deposit on the lid margins and contribute to blepharitis.

Casino environments compound the problem: recirculated air, cigarette smoke exposure, and extended screen time at gaming machines all increase evaporative stress on the ocular surface. Patients who work in hospitality, gaming, or any indoor environment with heavy air conditioning are at elevated risk for MGD-driven eyelid disease.

This is why Dr. Payne sees a higher-than-average rate of recurrent styes, chalazia, and blepharitis in her Las Vegas patient population — and why addressing the underlying gland dysfunction is especially important here.

Can a stye go away on its own? Some styes resolve spontaneously within one to two weeks, particularly if they drain on their own. However, styes that do not drain, styes that are large or painful, and styes that recur should be evaluated by an eye doctor. Attempting to squeeze or lance a stye at home risks spreading the infection and should be avoided.

Is a chalazion the same as a stye? No. A stye is an acute bacterial infection; a chalazion is a chronic, non-infectious granulomatous blockage of a meibomian gland. They can look similar from the outside, but they have different causes and different treatment approaches. A chalazion will not resolve with antibiotics alone and typically requires in-office treatment to clear.

How many Celluma LLLT sessions will I need? The number of sessions depends on the severity of your underlying MGD and blepharitis. Most patients with recurrent styes or chalazia benefit from a series of three to six sessions spaced one to two weeks apart, followed by periodic maintenance treatments. Dr. Payne will recommend a specific protocol after evaluating your eyelid health.

Does NuLids hurt? NuLids is well-tolerated by the vast majority of patients. The oscillating micro-tip creates a mild tingling sensation at the lid margin that most patients describe as comfortable. There is no anesthesia required and no recovery period after the procedure.

Will my insurance cover stye and chalazion treatment? Coverage varies by plan. Medical insurance (not vision insurance) may cover evaluation and treatment of acute styes and chalazia as a medical condition. Celluma LLLT and NuLids are typically not covered by insurance and are billed as out-of-pocket procedures. Dr. Payne's team will help you understand your coverage options when you call to schedule.

Can children be treated for recurrent styes? Yes. Recurrent styes in children are often a sign of blepharitis or MGD and should be evaluated rather than managed indefinitely with warm compresses. Dr. Payne sees pediatric patients and can tailor the treatment approach appropriately for younger patients.

If you are dealing with a current stye or chalazion, or if you have had recurrent eyelid lesions and want to address the underlying cause, Dr. Payne is accepting new patients at Trendsetter Eyewear in Summerlin, Las Vegas.

Call or text (702) 479-5222, or submit an appointment request at trendsettereyewear.com/contact. We are open Monday through Friday, 10:00 AM to 5:00 PM (closed 1:00–2:00 PM for lunch).

Trendsetter Eyewear 1225 S Fort Apache Rd #145 Las Vegas, NV 89117